PE Anti-PSGL-1 antibody [EPR28170-27],Abcam,AB325219

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Mouse, Mouse, Rat

Application

ICC/IF, IHC-P, Flow Cyt

Conjugate

PE

Platform ID

BAB803825916

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NamePE Anti-PSGL-1 antibody [EPR28170-27]
Cat. No.AB325219
HostRabbit
IsotypeIgG
ReactivityMouse, Mouse, Rat
ConjugationPE
ApplicationICC/IF, IHC-P, Flow Cyt
ClonalityMonoclonal
Clone NumberEPR28170-27
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Storage+4°C
Regulatory StatusResearch Use Only

Scientific Background

Target data A SLe(x)-type proteoglycan, which through high affinity, calcium-dependent interactions with E- and P-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture. See full target information Selplg

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.